With Semaglutide, youre not just on a treatment plan
Originally developed for the management of type 2 diabetes, tirzepatide quickly demonstrated remarkable efficacy for weight management, earning FDA approval and capturing the attention of patients and providers alike
After you eat, your intestines produce the GLP-1 hormone, which shuts off that hunger signal
The World Health Organization (WHO) has updated the list of essential medicines to include GLP-1s (semaglutide, dulaglutide and liraglutide) as well as the GLP-1/glucose-dependent insulinotropic polypeptide (GIP) dual receptor agonist (tirzepatide) as medicines for diabetes and obesity
Serious hypersensitivity reactions, including anaphylaxis and angioedema have been reported with Wegovy Important Safety Information WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures
The LifeMD Weight Management Program includes access to medications if appropriate and ongoing provider care